Showing results (1481-1490 of 1,853) with videos related to
Sort By:
Pageof 186
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.The Journal of Infectious Diseases|November 9, 2022
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a StudyDaniel J Stieh, Dan H Barouch, Christy Comeaux, et al.Science Advances|February 1, 2021
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidineAvani Yeola, Shruthi Subramanian, Rema A Oliver, et al.The Lancet. Infectious Diseases|August 14, 2010
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyKarthikeyan K Kumarasamy, Mark A Toleman, Timothy R Walsh, et al.Plos One|August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 studyYehuda Z Cohen, Allison L Butler, Katrina Millard, et al.The Lancet. Infectious Diseases|July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trialKathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.The Lancet. Infectious Diseases|June 8, 2020
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative studyYang Wang, Chunyan Xu, Rong Zhang, et al.The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.Nature Microbiology|March 30, 2021
Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countriesKirsty Sands, Maria J Carvalho, Edward Portal, et al.Ebiomedicine|September 22, 2023
Risk of COVID-19 after natural infection or vaccinationAnne-Marie Rick, Matthew B Laurens, Ying Huang, et al.Pageof 186